MX2021004860A - Piridazinas novedosas. - Google Patents
Piridazinas novedosas.Info
- Publication number
- MX2021004860A MX2021004860A MX2021004860A MX2021004860A MX2021004860A MX 2021004860 A MX2021004860 A MX 2021004860A MX 2021004860 A MX2021004860 A MX 2021004860A MX 2021004860 A MX2021004860 A MX 2021004860A MX 2021004860 A MX2021004860 A MX 2021004860A
- Authority
- MX
- Mexico
- Prior art keywords
- pyridazines
- novel
- novel pyridazines
- autotaxin
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La presente invención se refiere a piridazinas novedosas, procesos para su preparación, composiciones farmacéuticas que las contienen y su uso en los tratamientos, en particular, en el tratamiento y/o la prevención de enfermedades y trastornos mediados por autotaxina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18203226 | 2018-10-29 | ||
PCT/EP2019/079231 WO2020089098A1 (en) | 2018-10-29 | 2019-10-25 | Novel pyridazines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021004860A true MX2021004860A (es) | 2021-06-15 |
Family
ID=64048690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021004860A MX2021004860A (es) | 2018-10-29 | 2019-10-25 | Piridazinas novedosas. |
Country Status (19)
Country | Link |
---|---|
US (1) | US11104665B2 (es) |
EP (1) | EP3873472B1 (es) |
JP (1) | JP7214860B2 (es) |
KR (1) | KR20210084597A (es) |
CN (1) | CN112996513A (es) |
AR (1) | AR116877A1 (es) |
AU (1) | AU2019373324A1 (es) |
BR (1) | BR112021005445A2 (es) |
CA (1) | CA3113712A1 (es) |
CL (1) | CL2021000930A1 (es) |
DK (1) | DK3873472T3 (es) |
EA (1) | EA202191115A1 (es) |
ES (1) | ES2955723T3 (es) |
HU (1) | HUE063845T2 (es) |
IL (1) | IL282425B1 (es) |
MX (1) | MX2021004860A (es) |
PL (1) | PL3873472T3 (es) |
TW (1) | TW202035374A (es) |
WO (1) | WO2020089098A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020318697A1 (en) * | 2019-07-22 | 2022-01-27 | Boehringer Ingelheim International Gmbh | N-methyl, N-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases |
US11465982B2 (en) | 2019-07-22 | 2022-10-11 | Boehringer Ingelheim International Gmbh | Pyridazines |
US11485727B2 (en) * | 2019-07-22 | 2022-11-01 | Boehringer Ingelheim International Gmbh | N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103958481B (zh) * | 2011-10-28 | 2017-06-30 | 因西必泰克新有限公司 | 可用于治疗的哒嗪衍生物 |
PT2970255T (pt) | 2013-03-14 | 2017-09-05 | Galapagos Nv | Compostos e as suas composições farmacêuticas para o tratamento de doenças inflamatórias |
CN105339370B (zh) * | 2013-06-19 | 2017-09-15 | 加拉帕戈斯股份有限公司 | 用于治疗炎症性疾病的化合物和及其药物组合物 |
US9604974B2 (en) * | 2015-01-22 | 2017-03-28 | University Of Mysore | Compounds as modulator of JAK-STAT pathway, methods and applications thereof |
AU2020318697A1 (en) * | 2019-07-22 | 2022-01-27 | Boehringer Ingelheim International Gmbh | N-methyl, N-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases |
US11465982B2 (en) | 2019-07-22 | 2022-10-11 | Boehringer Ingelheim International Gmbh | Pyridazines |
US11485727B2 (en) * | 2019-07-22 | 2022-11-01 | Boehringer Ingelheim International Gmbh | N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators |
-
2019
- 2019-10-25 MX MX2021004860A patent/MX2021004860A/es unknown
- 2019-10-25 PL PL19801229.6T patent/PL3873472T3/pl unknown
- 2019-10-25 ES ES19801229T patent/ES2955723T3/es active Active
- 2019-10-25 CN CN201980071245.4A patent/CN112996513A/zh active Pending
- 2019-10-25 BR BR112021005445-6A patent/BR112021005445A2/pt unknown
- 2019-10-25 EP EP19801229.6A patent/EP3873472B1/en active Active
- 2019-10-25 KR KR1020217016497A patent/KR20210084597A/ko active Search and Examination
- 2019-10-25 IL IL282425A patent/IL282425B1/en unknown
- 2019-10-25 JP JP2021523198A patent/JP7214860B2/ja active Active
- 2019-10-25 WO PCT/EP2019/079231 patent/WO2020089098A1/en unknown
- 2019-10-25 AU AU2019373324A patent/AU2019373324A1/en active Pending
- 2019-10-25 CA CA3113712A patent/CA3113712A1/en active Pending
- 2019-10-25 DK DK19801229.6T patent/DK3873472T3/da active
- 2019-10-25 US US16/663,492 patent/US11104665B2/en active Active
- 2019-10-25 HU HUE19801229A patent/HUE063845T2/hu unknown
- 2019-10-25 EA EA202191115A patent/EA202191115A1/ru unknown
- 2019-10-28 TW TW108138765A patent/TW202035374A/zh unknown
- 2019-10-28 AR ARP190103115A patent/AR116877A1/es unknown
-
2021
- 2021-04-15 CL CL2021000930A patent/CL2021000930A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP7214860B2 (ja) | 2023-01-30 |
WO2020089098A1 (en) | 2020-05-07 |
CN112996513A (zh) | 2021-06-18 |
JP2022506046A (ja) | 2022-01-17 |
ES2955723T3 (es) | 2023-12-05 |
AU2019373324A1 (en) | 2021-04-22 |
DK3873472T3 (da) | 2023-09-04 |
US11104665B2 (en) | 2021-08-31 |
TW202035374A (zh) | 2020-10-01 |
AR116877A1 (es) | 2021-06-23 |
IL282425B1 (en) | 2024-03-01 |
EP3873472A1 (en) | 2021-09-08 |
CA3113712A1 (en) | 2020-05-07 |
IL282425A (en) | 2021-06-30 |
EA202191115A1 (ru) | 2021-09-06 |
CL2021000930A1 (es) | 2021-11-12 |
US20200131151A1 (en) | 2020-04-30 |
PL3873472T3 (pl) | 2023-12-27 |
HUE063845T2 (hu) | 2024-02-28 |
EP3873472B1 (en) | 2023-07-12 |
KR20210084597A (ko) | 2021-07-07 |
BR112021005445A2 (pt) | 2021-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020001187A (es) | Composiciones y métodos para la administración de virus adenoasociados. | |
PH12019502793A1 (en) | Aadc polynucleotides for the treatment of parkinson`s disease | |
MX2021009673A (es) | Moduladores de ror-gamma. | |
MX2020001513A (es) | Agentes de union a clec9a y su uso. | |
MX2018004755A (es) | Entrega de polinucleotidos dirigidos al sistema nervioso central. | |
PH12019500204A1 (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
PH12021550872A1 (en) | Therapeutic compounds | |
MX2019003363A (es) | Composiciones farmaceuticas para usarse en la terapia de la blefaritis. | |
PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
MX2021011507A (es) | Compuestos farmaceuticos para el tratamiento de trastornos mediados por complemento. | |
AU2018264384A1 (en) | Solid forms of berberine ursodeoxycholate and compositions and methods thereof | |
MX2021004860A (es) | Piridazinas novedosas. | |
MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
MX2018002446A (es) | Compuestos heterociclicos fusionados como moduladores s1p. | |
PH12019500535A1 (en) | 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof | |
MX2018008643A (es) | Derivados de 3-((hetero)aril)-8-amino-2-oxo-1,3-diaza-espiro-[4.5] -decano. | |
MX2020009566A (es) | Compuestos como moduladores de la se?alizacion de tlr2. | |
MX2018009662A (es) | Metodo y composicion farmaceutica para tratamiento de neurodegeneracion. | |
MX2020001256A (es) | Compuestos para la prevencion y el tratamiento de trastornos medicos y usos de los mismos. | |
MX2019014272A (es) | Compuestos policiclicos y usos de los mismos. | |
CR20210499A (es) | Compuestos y composiciones como moduladores de la señalización de tlr | |
PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
PH12018500682A1 (en) | Oxa-diazaspiro compounds having activity against pain | |
PH12017501694A1 (en) | Compositions for the treatment of fibrosis and fibrosis-related diseases | |
WO2017168454A3 (en) | Novel compounds as btk inhibitors |